LXU

LXU just printed a genuine operational rebound: FY2025 revenue rose 17.8% to $615M and operating income exploded from $4.6M-implied to $57.3M (+1,140%), driven largely by the absence of Turnarounds — the 10-K explicitly notes 2025 produced ~826,000 tons of ammonia vs. a 2024 year that suffered two Turnarounds. Net income swung from -$19.4M to +$24.6M and operating cash flow of $95.5M comfortably covered $77.5M of capex. Management's 2026 plan reads as steady-state blocking-and-tackling — reliability, mechanical integrity, productivity — not a transformational growth story.

The quality picture is mixed. Gross margin of 17.0% and ROE of 4.7% are unimpressive for a capital-intensive chemicals business, and the five-year revenue arc ($556M→$902M→$594M→$522M→$615M) and net-income whipsaw (FY2022's $230M peak collapsed to a FY2024 loss) confirm LXU is a commodity-price taker tied to ammonia/UAN pricing. The balance sheet is workable but not pristine: $440M of long-term debt against just $19.5M cash and $520M equity — manageable while OCF stays at ~$95M, but tight if nitrogen prices roll over. Current liabilities did drop 22% and current portion of debt is down 91.7%, easing near-term refinancing pressure.